Prot #BTCRC-LYM20-463: A Single Arm Phase I/II Study of Tazemetostat with Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma

Project: Research project

Project Details

StatusActive
Effective start/end date4/26/244/26/27

Funding

  • Hoosier Cancer Research Network, Inc. (Prot #BTCRC-LYM20-463 // Prot #BTCRC-LYM20-463)
  • Epizyme, Inc. (Prot #BTCRC-LYM20-463 // Prot #BTCRC-LYM20-463)